SC upholds FDA's regulatory authority over tobacco products

The Supreme Court has upheld its 2021 ruling affirming that the Food and Drug Administration (FDA) holds regulatory authority over tobacco products, including heated and novel products like vapes, based on health concerns.

In a July 23 decision, the court rejected motions for reconsideration filed by the Philippine Tobacco Institute (PTI) and Albay Representative Edcel Lagman, who challenged the FDA's jurisdiction.

Senior Associate Justice Marvic Leonen noted that the FDA Act grants regulatory authority over all products affecting health to the FDA, which includes tobacco products.

HealthJustice, a group of experts bridging the gap between health and law, welcomed the ruling as a landmark triumph in reducing tobacco consumption and its deadly consequences, especially among youth.

DOH Secretary Teodoro Herbosa stated that the ruling promotes and guarantees the health of Filipinos by protecting them from harmful effects of tobacco products.